Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, announced today that it has expanded the services and capabilities at its facility in Shiga, Japan, to include the storage, kitting, and distribution of advanced therapies at ultra- low temperatures for clinical trials. State-of-the-art cryogenic freezers alongside material transfer equipment […]

It takes only 0.146 seconds to love your brand, or at least it should. That’s how long it takes for someone to form a first impression of your brand. And if you’re not making an emotional connection with your audience in that fraction of a second, you’re missing out on a huge opportunity to win […]

TOP LINE: Mean lipid levels are similar among adolescents with and without major depressive disorder (MDD), as is the proportion of adolescents with borderline-high lipid levels. METHODOLOGY: Teen depression is associated with an increased likelihood of experiencing cardiovascular (CV) events, with dyslipidemia being a potentially modifiable risk factor. Only a few studies have examined the […]

A new study from Australia, New Zealand and Germany published in the New England Journal of Medicine raises important questions about the success or otherwise of emergency medicine. The study examined the drug tranexamic acid, which is commonly used to limit bleeding during surgery. However, its usefulness in emergency settings as a pre-emptive strike in […]

In today’s digital age, businesses are constantly seeking innovative ways to improve their lead generation strategies. Traditional methods can be time-consuming and may not always yield the desired results. However, with advancements in artificial intelligence (AI), businesses now have the opportunity to enhance their lead generation efforts and drive better outcomes. In this article, we […]

TOP LINE: Romosozumab (Evenity) is superior to denosumab (Prolia) in increasing bone mineral density (BMD) in patients with glucocorticoid-induced osteoporosis (GIOP). METHODOLOGY: Romosozumab is a US Food and Drug Administration-approved humanized monoclonal antibody used to treat osteoporosis in postmenopausal women with a high risk for fact. The study included 70 adults with GIOP with a […]

Drugs used to treat rare conditions are earning pharmaceutical companies almost as much as those marketed to the general public, according to a researcher at West Virginia University. Sean Tu, a College of Law professor found lucrative so-called “orphan” drugs earn manufacturing tax credits, have longer patent exclusivities and face easier Food and Drug Administration […]

Patients with “treatment-resistant depression” may be taking other medications with side effects that interfere with antidepressant efficacy. Investigators studied over 800 patients who were taking antidepressants for major depressive disorder (MDD) and found that close to two thirds were taking at least one nonpsychiatric medication with potential depressive symptom side effects (PDSS), more than 30% […]

Tufts Clinical and Translational Science Institute (CTSI) has received a $78.4 million Clinical and Translational Science Award from the NIH, the fourth consecutive grant since its founding in 2008. The grant provides federal funding over the next seven years to support research services, resources, and educational programs, and local, regional, and national initiatives. The award […]

MILAN, Italy — High-intensity interval training (HIIT) has been shown to enhance cardiorespiratory fitness (CRF) and mitigate cardiovascular disease (CVD) risk factors in patients with inflammatory joint diseases (IJD) in a randomized trial. Notably, the positive response in CRF did not coincide with changes in pain or fatigue. Kristine Norden, Center for Treatment of Rheumatic […]